A Multicenter Randomized Controlled Open-label Trial of Tenofovir Plus Entecavir Combination vs. Tenofovir Monotherapy in Chronic Hepatitis B Patients With Genotypic Resistance to Adefovir and Partial Virologic Response to Ongoing Treatment
Phase of Trial: Phase IV
Latest Information Update: 22 Feb 2018
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Entecavir
- Indications Hepatitis B
- Focus Therapeutic Use
- 18 Feb 2018 Status changed from active, no longer recruiting to completed.
- 24 Jun 2015 Planned End Date changed from 1 Jun 2014 to 1 Feb 2018 as reported by ClinicalTrials.gov.
- 09 Apr 2014 Preliminary results after 36 weeks of treatment presented at the 49th Annual Meeting of the European Association for the Study of the Liver.